Kidney study checks drug safety in 16 volunteers
NCT ID NCT05004311
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 20 times
Summary
This study tested how the drug cenerimod is processed by the body in people with severe kidney impairment compared to healthy volunteers. A total of 16 adults received a single dose, and researchers measured drug levels and safety markers like heart activity and blood pressure. The goal was to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BlueClinical Phase 1 Hospital de Prelado
Porto, 4250-449, Portugal
Conditions
Explore the condition pages connected to this study.